On Invalid Date, Molecular Partners Ag (NASDAQ: MOLN) reported Q4 2023 earnings per share (EPS) of -$0.71, up 22.89% year over year. Total Molecular Partners Ag earnings for the quarter were -$23.55 million. In the same quarter last year, Molecular Partners Ag's earnings per share (EPS) was -$0.58.
As of Q2 2024, Molecular Partners Ag's earnings has grown year over year. Molecular Partners Ag's earnings in the past year totalled -$70.44 million.
What was MOLN's revenue last quarter?
On Invalid Date, Molecular Partners Ag (NASDAQ: MOLN) reported Q4 2023 revenue of $1.23 million up 57.62% year over year. In the same quarter last year, Molecular Partners Ag's revenue was $2.90 million.
What was MOLN's revenue growth in the past year?
As of Q2 2024, Molecular Partners Ag's revenue has grown -95.89% year over year. This is 247.35 percentage points lower than the US Biotechnology industry revenue growth rate of 151.46%. Molecular Partners Ag's revenue in the past year totalled $8.00 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.